Lilly is following this with retatrutide, a triple agonist, which has completed phase 2 trials for treating obesity and cardiovascular disease
GoodRx has also announced pricing assistance, with some pharmacies offering the lower dosages (1.5 mg and 4 mg) for as little as $149 per month
Media reports describe it as a loophole, says Alliance for Pharmacy Compounding CEO Scott Brunner
Gradual dosing, regular check-ins, and patience are key, results vary by individual
Its your dedication to these lifestyle adjustments that truly enhances the effectiveness of the treatment and helps in achieving the desired weight loss results with weight loss medications
This led to Ozempic gaining FDA approval for weight loss in addition to blood sugar control